Jinyi Zhu

7PUBLICATIONS
68CO-AUTHORS
Tumour immunologyMolecular targetsHaematological tumoursBiologically active moleculesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 01, 2026
Discovery of BMS-986449: A Potent, Selective Degrader of the Transcription Factors IKZF2 (Helios) and IKZF4 (Eos) to Target Regulatory T Cells in Solid Tumors.

|Jun 29, 2026
NSD2 degradation remediates the oncogenic cistrome in t(4;14) multiple myeloma.

|Feb 11, 2026
Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma.

Deborah S Mortensen, Hunter P Shunatona, Natalie Holmberg-Douglas

|Nov 03, 2025
Golcadomide: An Oral CELMoD Agent Targeting IKZF1/3 for Diffuse Large B-cell Lymphoma.

Zhongying Mo, Lynda Groocock, Scott Wood

|Oct 07, 2025
Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760.

Hunter P Shunatona, Natalie Holmberg Douglas, Jayce Rhodes

|Nov 15, 2022
Molecular glue CELMoD compounds are regulators of cereblon conformation.

Edmond R Watson, Scott Novick, Mary E Matyskiela

Pageof 2

Frequent Collaborators

3 joint publications

Lihong Shi

3 joint publications

Deborah S Mortensen

2 joint publications

Sophie Peng

2 joint publications

Diana Jankeel